Welcome to LookChem.com Sign In|Join Free
  • or
6-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yloxy)nicotinonitrile is a complex organic chemical compound with the molecular formula C12H7BN2O3. It is a derivative of nicotine, featuring a benzo[c][1,2]oxaborole moiety attached to the 6-position of the nicotine molecule. 6-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yloxy)nicotinonitrile is of interest in chemical research, particularly in the field of cross-coupling reactions, where it can serve as a valuable intermediate or building block for the synthesis of more complex molecules. The presence of the hydroxy group and the nitrile group in the molecule allows for further functionalization and modification, making it a versatile component in organic synthesis.

943311-33-9

Post Buying Request

943311-33-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

943311-33-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 943311-33-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,3,3,1 and 1 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 943311-33:
(8*9)+(7*4)+(6*3)+(5*3)+(4*1)+(3*1)+(2*3)+(1*3)=149
149 % 10 = 9
So 943311-33-9 is a valid CAS Registry Number.

943311-33-9Downstream Products

943311-33-9Relevant academic research and scientific papers

Boron-Containing Small Molecules as Anti-Inflammatory Agents

-

, (2015/11/16)

Compounds and methods of treating anti-inflammatory conditions are disclosed.

Design and synthesis of boron-containing PDE4 inhibitors using soft-drug strategy for potential dermatologic anti-inflammatory application

Zhang, Yong-Kang,Plattner, Jacob J.,Akama, Tsutomu,Baker, Stephen J.,Hernandez, Vincent S.,Sanders, Virginia,Freund, Yvonne,Kimura, Richard,Bu, Wei,Hold, Karin M.,Lu, Xiao-Song

experimental part, p. 2270 - 2274 (2010/07/05)

PDE4 inhibitors are a validated approach as anti-inflammatory agents but are limited by systemic side effects including emesis. We report a soft-drug strategy incorporating a carboxylic ester group into boron-containing PDE4 inhibitors leading to the discovery of a series of benzoxaborole compounds with good potency (for example IC50 = 47 nM of compound 2) and low emetic activity. These compounds are intended for dermatological use further limiting possible systemic side effects.

BORON-CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS

-

Page/Page column 48; 51, (2008/06/13)

Methods of treating anti-inflammatory conditions through the use of boron-containing small molecules are disclosed.

Compounds for the Treatment of Periodontal Disease

-

Page/Page column 49; 51, (2008/06/13)

Compounds, compositions and methods are provided which are useful in the treatment of periodontal disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 943311-33-9